Eckert & Ziegler SE (CHIX:EUZD) Marketable Securities: €0.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:EUZD Eckert & Ziegler SE CHIX:EUZD
94 GF Score
Price €15.19
GF Value €18.55
Valuation Fairly Valued
View Full Analysis

What is Eckert & Ziegler SE Marketable Securities?

Eckert & Ziegler SE CHIX:EUZD 94 Marketable Securities is €0.1 Mil as of Mar. 2026. GuruFocus rates CHIX:EUZD with a GF Score™ of 94/100 and a GF Value™ of €18.55 (Fairly Valued).

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Eckert & Ziegler SE's Marketable Securities for the quarter that ended in Mar. 2026 was €0.1 Mil.

Eckert & Ziegler SE's annual Marketable Securities increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.1 Mil) but then declined from Dec. 2024 (€0.1 Mil) to Dec. 2025 (€0.1 Mil).

Eckert & Ziegler SE  (CHIX:EUZd) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Eckert & Ziegler SE Marketable Securities Related Terms

Eckert & Ziegler SE Marketable Securities Historical Data

* Premium members only.

The historical data trend for Eckert & Ziegler SE's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eckert & Ziegler SE Marketable Securities Chart

Eckert & Ziegler SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.36 0.00 0.00 0.14 0.07

Eckert & Ziegler SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.00 0.09 0.07 0.09
CHIX:EUZD
94GF Score
Eckert & Ziegler SE CHIX:EUZD
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eckert & Ziegler SE Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.1 Mil mean?
Eckert & Ziegler SE (CHIX:EUZD) has a Marketable Securities of €0.1 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Eckert & Ziegler SE and its competitors.
Is Eckert & Ziegler SE's Marketable Securities too high?
Eckert & Ziegler SE's current Marketable Securities is €0.1 Mil. Overall, Eckert & Ziegler SE has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's Marketable Securities compare to ABT and SYK?
Eckert & Ziegler SE's Marketable Securities of €0.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Eckert & Ziegler SE and its competitors. Eckert & Ziegler SE's current Marketable Securities is €0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (CHIX:EUZD) is currently considered Fairly Valued. The stock's GF Value™ is €18.55, compared to a current price of €15.19 — trading 18.1% below its estimated fair value. The current Marketable Securities is €0.1 Mil. Eckert & Ziegler SE's overall GF Score™ is 94/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Eckert & Ziegler SE (CHIX:EUZD), the current Marketable Securities is €0.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eckert & Ziegler SE (CHIX:EUZD) Overvalued in 2026?

Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued. The current stock price of €15.19 is trading 18.1% below its estimated GF Value™ of €18.55. GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.

Key valuation signals for CHIX:EUZD:

  • Marketable Securities: €0.1 Mil
  • GF Value™: €18.55 vs. price of €15.19 (18.1% below fair value)
  • GF Score™: 94/100

No single metric tells the full story. See the CHIX:EUZD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eckert & Ziegler SE Business Description

Address Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
94GF Score

Get the complete analysis for CHIX:EUZD

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.19
Price
€18.55
GF Value